Micro-Tech Endoscopy Announces LesionHunter Cold Snare

Micro-Tech Endoscopy launched the LesionHunter Cold Snare, a novel cold snare with an ultra-thin Nitinol wire. Key features include:

  • Thin Monofilament Nitinol Wire – this wire material provides durability in the shape and allows for a 0.18mm thin wire for a clean and precise cut.
  • Coiled Sheath – the coiled metal catheter creates greater stability for the guillotine-like cutting action of the wire.
  • Reduced Fly-Away Tissue – the thin wire may reduce the risk of generating a “fly-away” specimen; thereby making it easier to find the tissue at the end of the resection.

“The LesionHunter is a unique cold snare with two great features, the ability to trap the tissue regardless of how flat the lesion is, and the ‘cheese cutter’ capability to resect even larger lesions,” commented Gastroenterologist and Advanced Endoscopist at NYU Langone, Gregory Haber, M.D. “It has become my go-to for cold snare applications.”

The LesionHunter nitinol snare was specifically designed to advance cold snare polypectomy.

“The LesionHunter nitinol wire is 61% thinner than traditional braided snare wires and 42% thinner than the most popular braided cold snare on the market,” Micro-Tech’s Executive Global R&D Director Scott Haack said. “The thin Nitinol wire allows for multiple tissue resections while maintaining its shape along with the ability to make a clean cut through large pieces of tissue. Current dedicated cold snares and hybrid hot/cold snares can’t consistently accomplish this.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”